California Voters Face $8.4 Billion Bond to Fund Immunology Research
Proposition 38 would let California borrow $8.4 billion to fund immunotherapy research, allocating half of the money to a UC-linked institute.
Proposition 38, slated for the November ballot, would authorize $8.4 billion in state bonds to subsidize immunotherapy research targeting cancer, Alzheimer’s disease and heart conditions. Half of the proceeds are designated for the California Institute for Immunology and Immunotherapy, a UC-affiliated nonprofit founded by billionaire surgeon Gary Michelson, who also contributed $61 million to the campaign; the remaining $4.2 billion would be distributed to selected nonprofit and research entities.
Any medicines developed must be sold to Californians at a 20 percent discount, with 10 percent of revenue returned to the state. Support comes from the American Association of Immunologists and Alzheimer’s San Diego, while critics including the League of Women Voters, the Howard Jarvis Taxpayers Association, and several state legislators argue the bond concentrates funds on one organization and misuses public money. The proposal is part of a trio of large bond measures, with Prop. 1 funding affordable housing and Prop. 37 creating a loan program for homebuyers, prompting atypical alliances across party lines. Statements from Republican Assemblymember Carl DeMaio, Assemblymember Chris Ward, and various local campaign managers illustrate the political complexity surrounding the initiative.
Why it matters
The bond could reshape California's biomedical funding and affect how public money supports health research.
How the sides frame it
LOW AGREEMENTLeft-leaning coverage zeroes in on Proposition 38’s $8.4 billion immunology bond, detailing its structure, beneficiaries and criticism, while centrist coverage treats Proposition 38 as one of three ballot bonds, emphasizing the overall $44 billion debt package and its fiscal implications.
LEFT
Focuses on the specifics of the $8.4 billion immunology bond, highlighting the discount requirement for medicines, the role of billionaire donor Gary Michelson, and the opposition from groups like the League of Women Voters.
CENTER
Frames the bond measures as a large, combined $44 billion borrowing package, describing them as “borrow-now, pay-back-later” proposals that could flood the state’s housing and research sectors with debt.
The left emphasises
- Proposition 38 would authorize $8.4 billion in bonds for immunotherapy research.
- Medicines developed must be sold to Californians at a 20 percent discount, with 10 percent of revenue returned to the state.
- Critics include the League of Women Voters and the Howard Jarvis Taxpayers Association.
In this story
